通用流感疫苗的保护作用由记忆CD4 T细胞介导
研究开发了一种新型通用流感疫苗,在小鼠和人模型中诱导针对多种流感病毒的稳健T细胞应答和保护。疫苗介导的保护依赖流感特异性CD4+ T细胞,接种或攻击时去除CD4+ T细胞显著降低小鼠生存率。疫苗记忆CD4+ T细胞为早期抗体产生和CD8+ T细胞回忆应答所需,且疫苗可增强人PBMC中H5特异性CD4+和CD8+效应记忆T细胞。
要点
- 新型通用流感疫苗在小鼠和人模型中诱导针对多种流感病毒的T细胞应答和保护。
- 疫苗保护依赖流感特异性CD4+ T细胞,去除CD4+ T细胞显著降低小鼠生存率。
- 疫苗增强人PBMC中H5特异性CD4+和CD8+效应记忆T细胞。
核心结论
- 通用流感疫苗介导的保护由疫苗记忆CD4+ T细胞介导,这些细胞为早期抗体产生和CD8+ T细胞回忆应答所需。
- 疫苗在人PBMC中增强H5特异性CD4+和CD8+效应记忆T细胞,支持其作为通用疫苗的潜力。
研究设计与样本
- 研究在小鼠和人模型(人PBMC)中评估新型通用流感疫苗的免疫原性和保护效果。
主要发现
- 在小鼠中,接种或攻击时去除CD4+ T细胞显著降低生存率。
- 疫苗记忆CD4+ T细胞为早期抗体产生和CD8+ T细胞回忆应答所需。
- 疫苗接种后的流感特异性CD4+ T细胞主要呈现Tfh和Th1表型并产生抗病毒细胞因子。
- 疫苗增强人PBMC中H5特异性CD4+和CD8+效应记忆T细胞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a diverse array of influenza viruses which circulate between different species, reassort and drift over time. Current seasonal influenza vaccines are ineffective in controlling these viruses. We have developed a novel universal vaccine which elicits robust T cell responses and protection against diverse influenza viruses in mouse and human models. Vaccine mediated protection was dependent on influenza-specific CD4+ T cells, whereby depletion of CD4+ T cells at either vaccination or challenge time points significantly reduced survival in mice. Vaccine memory CD4+ T cells were needed for early antibody production and CD8+ T cell recall responses. Furthermore, influenza-specific CD4+ T cells from vaccination manifested primarily Tfh and Th1 profiles with anti-viral cytokine production. The vaccine boosted H5-specific T cells from human PBMCs, specifically CD4+ and CD8+ T effector memory type, ensuring the vaccine was truly universal for its future application. These findings have implications for the development and optimization of T cell activating vaccines for universal immunity against influenza.
引用
- Valkenburg SA, Li OTW, Li A, et al. Protection by universal influenza vaccine is mediated by memory CD4 T cells. Vaccine. 2018. PMID: 29887326. doi:10.1016/j.vaccine.2018.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。